Stock EWL EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Edwards Lifesciences Corporation Xetra

Equities

EWL

US28176E1082

Market Closed - Xetra
Other stock markets
 16:35:41 17/05/2024 BST 		After market 18:17:51
81.79 EUR -1.53% Intraday chart for Edwards Lifesciences Corporation 81.8 +0.02%
05-14 Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
05-13 Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Edwards Lifesciences : First Quarter 2024 Fact Sheet
PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
BU
Edwards Lifesciences: Q1 Earnings Snapshot
AQ
Edwards Lifesciences Reports First Quarter Results
BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It
AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)
AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE
AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
BU
Edwards Lifesciences: Q4 Earnings Snapshot
AQ
Edwards Lifesciences Reports Fourth Quarter Results
BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?
AQ
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BU
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
BU
CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION
PR
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EW Stock
  4. EWL Stock
  5. News Edwards Lifesciences Corporation
  6. Press Releases